The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...
The study reveals how solvent molecules can modulate pain signals, offering a potential pathway for a safer ... it suppressed pain signal transmission and achieved effective analgesia.
In a new study, scientists at the Leibniz Institute for Neurobiology (LIN) and University Hospital Magdeburg demonstrated ...